当前位置:首页 - 行情中心 - 江中药业(600750) - 财务分析 - 现金流量表

江中药业

(600750)

  

流通市值:141.96亿  总市值:143.37亿
流通股本:6.29亿   总股本:6.35亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,636,584,505.282,597,169,886.041,045,771,755.844,354,670,028.38
  收到的税费返还1,410,232.721,410,232.7241,786.83956,585.52
  收到其他与经营活动有关的现金105,533,269.0880,211,490.3448,095,944.12105,206,268.76
  经营活动现金流入小计3,743,528,007.082,678,791,609.11,093,909,486.794,460,832,882.66
  购买商品、接受劳务支付的现金759,705,298.51590,947,386.11230,671,799.131,109,066,821.27
  支付给职工以及为职工支付的现金545,878,293.28389,472,250.4207,750,006.08714,824,800.58
  支付的各项税费477,954,582.32353,581,625.77148,211,368.66533,430,518.24
  支付其他与经营活动有关的现金986,215,530.89693,002,671.55330,532,952.691,317,258,193.66
  经营活动现金流出小计2,769,753,7052,027,003,933.83917,166,126.563,674,580,333.75
  经营活动产生的现金流量净额973,774,302.08651,787,675.27176,743,360.23786,252,548.91
二、投资活动产生的现金流量:
  收回投资收到的现金1,098,000,000747,000,000180,000,0001,230,150,000
  取得投资收益收到的现金25,644,794.3620,823,350.3717,309,222.3973,686,716.34
  处置固定资产、无形资产和其他长期资产收回的现金净额85,825.8846,968.119,603.4613,890,727.65
  收到的其他与投资活动有关的现金---49,226,987.58
  投资活动现金流入小计1,123,730,620.24767,870,318.47197,328,825.851,366,954,431.57
  购建固定资产、无形资产和其他长期资产支付的现金203,501,881.05108,039,700.646,907,046.41290,767,424.88
  投资支付的现金1,393,649,031.58987,854,031.58280,000,000995,217,555.12
  取得子公司及其他营业单位支付的现金7,000,000---
  投资活动现金流出小计1,604,150,912.631,095,893,732.18326,907,046.411,285,984,980
  投资活动产生的现金流量净额-480,420,292.39-328,023,413.71-129,578,220.5680,969,451.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金83,953,60083,953,600--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计83,953,60083,953,600--
  分配股利、利润或偿付利息支付的现金460,473,879.7457,339,645.66-768,458,565.77
  支付其他与筹资活动有关的现金1,819,594.71,441,453.158,080.0688,980,022.17
  筹资活动现金流出小计462,293,474.4458,781,098.7658,080.06857,438,587.94
  筹资活动产生的现金流量净额-378,339,874.4-374,827,498.76-58,080.06-857,438,587.94
五、现金及现金等价物净增加额115,014,135.29-51,063,237.247,107,059.619,783,412.54
  加:期初现金及现金等价物余额651,924,308.69651,924,308.69651,924,308.69642,140,896.15
  期末现金及现金等价物余额766,938,443.98600,861,071.49699,031,368.3651,924,308.69
补充资料:
  净利润-559,418,824.32-860,506,989.31
  资产减值准备--9,673,397.62-16,072,851.21
  固定资产和投资性房地产折旧-62,753,296.08-116,075,444.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-62,753,296.08-116,075,444.59
  无形资产摊销-10,223,750.07-19,218,501.23
  长期待摊费用摊销-492,447.43-943,796.67
  处置固定资产、无形资产和其他长期资产的损失--992.41--1,837,913.47
  固定资产报废损失-513,522.27-1,048,220.28
  公允价值变动损失--681,003.71-8,626,804.43
  财务费用--39,852,034.03--73,208,941.08
  投资损失-1,171,137.15-976,900
  递延所得税--12,668,194.8--12,777,758.36
  其中:递延所得税资产减少--11,632,507.66--10,551,369.01
    递延所得税负债增加--1,035,687.14--2,226,389.35
  存货的减少--19,098,526.69-10,820,849.64
  经营性应收项目的减少-198,884,945.43--326,866,702.65
  经营性应付项目的增加--103,835,774.63-175,969,462.46
  其他-4,559,358.42-3,633,303.54
  现金的期末余额-600,861,071.49-651,924,308.69
  减:现金的期初余额-651,924,308.69-642,140,896.15
  现金及现金等价物的净增加额--51,063,237.2-9,783,412.54
公告日期2025-10-252025-08-222025-04-262025-03-20
审计意见(境内)标准无保留意见
TOP↑